Research Article
IL-17 Genetic and Immunophenotypic Evaluation in Chronic Graft-versus-Host Disease
Table 3
Association between saliva IL-17A levels and recipient
IL17A genotypes (
).
| | | Days | Genotype |
valid& | IL-17A
median | Minimum
levels | Maximum
levels | |
| | Blood levelsa | +35 | GG | 14 | 22.42 | 0.00 | 849.80 | 0.007 | | AG | 13 | 49.25 | 0.00 | 480.14 | | AA | 11 | 0.00 | 0.00 | 39.56 | | +100 | GG | 8 | 3.59 | 0.00 | 178.00 | NS | | AG | 12 | 0.00 | 0.00 | 116.00 | | AA | 8 | 0.00 | 0.00 | 44.02 |
| | Saliva levelsb | +35 | GG | 10 | 0.00 | 0.00 | 5.78 | NS | | AG | 10 | 1.62 | 0.00 | 21.74 | | AA | 9 | 0.00 | 0.00 | 11.12 | | +100 | GG | 9 | 0.00 | 0.00 | 27.00 | NS | | AG | 8 | 0.76 | 0.00 | 54.12 | | AA | 7 | 0.00 | 0.00 | 21.23 |
|
|
NS: not significant; A: absent; P: present; Kruskal Wallis test; pg/mL; pg/mg protein.
&Number of valid samples in each moment.
|
